stars 1 stars 2 stars 3

Among the largest 'Vertically Integrated'​ pharmaceutical companies in India, Aurobindo has robust product portfolio spread over major product areas encompassing CVS, CNS, Anti-Retroviral, Antibiotics, Gastroenterologicals, Anti-Diabetics and Anti-Allergic with approved manufacturing facilities by USFDA, UKMHRA, WHO, MCC-SA, ANVISA-Brazil for both APIs & Formulations and has Global presence with own infrastructure, strategic alliances, subsidiaries & joint ventures. Aurobindo’s R & D strengths lie in developing intellectual property in non-infringing processes and resolving complex chemistry challenges. In the process, Aurobindo develops new drug delivery systems, dosage formulations and applies new technology for better processes.

Aurobindo Pharma Questions

The Aurobindo Pharma annual revenue was $3.5 billion in 2026.

Gopa Ravindranath is the Vice President - Formulations of Aurobindo Pharma.

3,930 people are employed at Aurobindo Pharma.

Aurobindo Pharma is based in Hyderabad, Telangana.

The NAICS codes for Aurobindo Pharma are [32, 3254, 325, 32541].

The SIC codes for Aurobindo Pharma are [28, 283].

Top Aurobindo Pharma Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users